Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;17(6):e2330.
doi: 10.1002/rcs.2330. Epub 2021 Sep 22.

Robotic surgery for colorectal liver metastases resection: A systematic review

Aldo Rocca  1 , Andrea Scacchi  1 , Micaela Cappuccio  1 , Pasquale Avella  1 , Walter Bugiantella  2 , Michele De Rosa  2 , Gianluca Costa  3 , Andrea Polistena  4 , Massimo Codacci-Pisanelli  4 , Bruno Amato  5 , Fabio Carbone  6 , Graziano Ceccarelli  2
Affiliations

Robotic surgery for colorectal liver metastases resection: A systematic review

Aldo Rocca et al. Int J Med Robot. 2021 Dec.

Abstract

Background: The role of robotic surgery for colorectal cancer liver metastases (CRCLMs) has never been investigated in large series.

Methods: A systematic literature review was carried out on PubMed and Cochrane libraries.

Results: We selected nine studies between 2008 and 2021. Two hundred sixty-two patients were included. One hundred thirty-one patients underwent simultaneous resections. The mean blood loss was 309.4 ml (range, 200-450 ml), the mean operative time was 250.5 min (range, 198.5-449.0 min). The mean length of hospital stay was 7.98 days (range, 4.5 to 12 days). The overall postoperative mortality was 0.4%. The overall morbidity rate was 37.0%, Clavien-Dindo grade III-IV complications were 8.4%. The mean 3-year overall survival was 55.25% (range, 44.4-66.1%), the mean 3-year disease free survival was 37% (range, 33.3-41.9%) CONCLUSION: We can conclude that robotic-assisted surgery might be considered as a technical upgrade option for minimally invasive approach to CRCLM resections even for simultaneous operations and challenging cases.

Keywords: colorectal liver metastases; robotic surgery; systematic review.

PubMed Disclaimer

References

REFERENCES

    1. Cancer WHOIAfRo. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012; Accessed November 17, 2014. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
    1. Lykoudis PM, O'Reilly D, Nastos K, Fusai G. Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg. 2014;101(6):605-612.
    1. Nordlinger B, Van Cutsem E, Rougier P, et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Canc. 2007;43(14):2037-2045.
    1. Nordlinger B, Van Cutsem E, Gruenberger T, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol. 2009;20(6):985-992.
    1. Adam R, de Gramont A, Figueras J, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729-741.

Publication types

LinkOut - more resources